Solesence, Inc. (SLSN): who owns it and who trades it
As of Nov 16, 2026, SLSN insiders reported 6 purchases worth $33.8K in the last 12 months. The largest buyer was R Janet Whitmore (Director), with $33.8K. 1 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Solesence
From the latest filingsOverall: about as much buying as selling. Famous investors mostly sold. Insiders mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Insider trades
In the last 12 months, SLSN insiders reported $33.8K of open-market purchases and $0 of sales.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Dec 24, 2025 | R Janet Whitmore | Director | Purchase | 1,000 | $1.92 | $1.9K | Form 4 |
| Dec 24, 2025 | R Janet Whitmore | Director | Purchase | 1,500 | $1.91 | $2.9K | Form 4 |
| Nov 19, 2025 | R Janet Whitmore | Director | Purchase | 5,000 | $1.95 | $9.8K | Form 4 |
| Nov 19, 2025 | R Janet Whitmore | Director | Purchase | 5,000 | $1.89 | $9.4K | Form 4 |
| Nov 18, 2025 | R Janet Whitmore | Director | Purchase | 267 | $1.83 | $489 | Form 4 |
| Nov 17, 2025 | R Janet Whitmore | Director | Purchase | 5,000 | $1.87 | $9.3K | Form 4 |
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| R Janet Whitmore | Director | $33.8K | – | Dec 24, 2025 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
SLSN short interest
Low short interest. 0.5% of SLSN shares are sold short: about 1 share in 197. Over the last 12 reports the number of shares short went down 55%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 359,433 SLSN shares were sold short, 0.5% of the shares outstanding, down 2.3% from the report before. At the average daily volume of 18,454 shares, buying them all back would take about 19.5 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 359,433 | 0.51% | -2% | 18,454 | 19.5 |
| Oct 15, 2026 | 367,758 | 0.52% | -4% | 48,141 | 7.6 |
| Sep 30, 2026 | 381,657 | 0.54% | +3% | 15,225 | 25.1 |
| Sep 15, 2026 | 369,742 | 0.52% | +1% | 21,476 | 17.2 |
| Aug 31, 2026 | 366,870 | 0.52% | -2% | 15,465 | 23.7 |
| Aug 14, 2026 | 376,101 | 0.53% | -5% | 24,880 | 15.1 |
| Jul 31, 2026 | 397,306 | 0.56% | -7% | 55,856 | 7.1 |
| Jul 15, 2026 | 427,618 | 0.61% | +10% | 205,035 | 2.1 |
| Jun 30, 2026 | 389,460 | 0.55% | -49% | 254,019 | 1.5 |
| Jun 15, 2026 | 757,817 | 1.07% | -7% | 35,437 | 21.4 |
| May 29, 2026 | 819,131 | 1.16% | +2% | 39,480 | 20.8 |
| May 15, 2026 | 801,431 | 1.13% | -1% | 39,277 | 20.4 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Solesence company events
Solesence filed 10 reports on Form 8-K in the last 12 months, 5 of them about an important change (leadership, listing, restatement). The latest was on Oct 5, 2026.
- Oct 5, 2026AgreementSolésence, Inc. entered into a (i) Fourth Amendment to Business Loan Agreement with Strandler, LLC, an affiliate of our controlling shareholder, Bradford T. Whitmore, (ii) Fourth Amendment to Amended and Restated Business Loan Agreement with Beachcorp, LLC, which is also an affiliate of our… Filing
- Oct 2, 2026ListingSolésence, Inc. received a written notice from the Listing Qualifications Department of Nasdaq Stock Market indicating that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive trading days, the Company was no longer in compliance with… Filing
- Aug 21, 2026RestatementAs previously disclosed in its Quarterly Report on Form 10-Q filed August 19, 2026, during its review of inventory accounting in connection with the preparation of its unaudited condensed consolidated financial statements for the quarter ended June 30, 2026, Solésence, Inc. identified errors in its… Filing
- Aug 20, 2026ResultsReleased financial results. Filing
- Jul 10, 2026AgreementSolésence, LLC, a wholly owned subsidiary of Solésence, Inc., entered into a Settlement Agreement and Release with Refy Beauty Ltd. Filing
- May 12, 2026ResultsReleased financial results. Filing
- Apr 29, 2026LeadershipThe Board of Directors of the Company appointed Marc James to serve as a Class II Director of the Board for the remainder of the term of Class II Directors of the Board, expiring at the 2026 Annual Meeting of Shareholders of the Company. Filing
- Mar 31, 2026ResultsReleased financial results. Filing
- Dec 3, 2025LeadershipDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. Filing
- Dec 1, 2025LeadershipAs disclosed in Item 1.01 of this current report on Form 8-K, which is incorporated into this Item 5.02, effective November 21, 2025, Jess Jankowski retired and resigned from his position on the Board of Directors of the Company. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Solesence financials
Famous investors that hold SLSN
1 of the 50 well-known investors we track reported holding SLSN in their latest 13F filing. The largest position is Israel Englander's, worth $215K.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Israel Englander · Millennium Management | Q3 2026 | 262,524 | $215K | 0.0% | -5% |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
5%+ stakes filed in the last 120 days
Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named SLSN in the last 120 days.
| Filed | Holder | Form | Stake |
|---|---|---|---|
| Nov 9, 2026 | WHITMORE BRADFORD T | 13D/A | 70.5% |
| Nov 9, 2026 | WHITMORE BRADFORD T | 13D/A | 70.5% |
Questions about Solesence, Inc. (SLSN) stock
Are SLSN insiders buying or selling?
In the last 12 months, SLSN insiders reported 6 open-market purchases worth $33.8K and no sales. The latest trade was on Dec 24, 2025. See every trade.
What is the short interest in SLSN?
As of Oct 30, 2026, 359,433 SLSN shares were sold short, 0.5% of the shares outstanding, down 2.3% from the report before. At the average daily volume of 18,454 shares, buying them all back would take about 19.5 trading days (days to cover). See the history.
Which famous investors hold SLSN?
1 of the 50 well-known investors we track reported SLSN in their latest 13F filing, including Israel Englander. The largest position is worth $215K. See all holders.
Executive pay
Solesence's chief executive was paid a total of $426K for the year ended Dec 31, 2025. In the last 12 months, Solesence's executives and directors bought $68.1K of stock on the open market and sold none.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.